Transcripts Freenome, Inc.

Stocks

End-of-day quote Nasdaq Other stock markets 2026-07-27			5-day change	1st Jan Change
11.38 ^USD	+1.25%		-12.53%	-12.66%

07-27	Freenome, Inc. Announces FDA Approval of SimpleScreen CRC Blood-Based Screening Test and Abbott to Commercialize in the U.S	CI
07-27	FDA approves Freenome's blood test for colorectal cancer screening	RE

No results match your criteria